Breast Friends Fund (BFF)
Eric P. Winer, MD, is Senior Vice President for Medical Affairs and Chief Clinical Strategy Officer for Dana-Farber, Director of the Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers, and the
Thompson Chair in Breast Cancer Research at Dana-Farber Cancer Institute.

He is also Professor of Medicine at Harvard Medical School, Leader of the Breast Cancer Program in the Dana-Farber/Harvard Cancer Center, and Program Director for the Dana-Farber/Harvard Cancer Center SPORE grant in breast cancer. At Dana-Farber, Dr. Winer leads a multidisciplinary group of clinicians and investigators focused on the treatment of individuals with breast cancer and identifying improved approaches to treatment.

Dr. Winer is the former Senior Scientific Advisor and past Co-Chair of the Scientific Advisory Board for Susan G. Komen for the Cure. He is a prolific contributor to oncology, scientific, and clinical literature, authoring research articles, editorials, and textbook chapters.

​In 2009, he received the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School, and in 2013 he received the Advancing the Careers of Women Faculty Award from Dana-Farber Cancer Institute. Dr. Winer is also the recipient of the 2016 William L. McGuire Memorial Lecture Award at the San Antonio Breast Cancer Symposium for significant contributions to breast cancer research, and the 2017 recipient of the Gianni Bonadonna Award at the annual meeting of the American Society of Clinical Oncology, and he will be the recipient of the Brinker Award for distinction in breast cancer clinical research in December 2018.

He received his undergraduate and medical degrees from Yale University, then trained in internal medicine and served as Chief Resident at Yale-New Haven Hospital. Dr. Winer was a fellow at Duke University Medical Center from 1987 through 1989 and then remained on the faculty until 1997. He joined the Dana-Farber faculty in 1997.






Senior Vice President, Medical Affairs
Chief Clinical Strategy Officer
Chief, Division of Breast Oncology
Thompson Chair in Breast Cancer Research

Dr. Eric Winer